Last updated: February 13, 2026
What Is the Market Outlook for NDC 64764-0544?
NDC 64764-0544 refers to a specific drug product, identified by the National Drug Code (NDC). To analyze market potential and price projections, it is necessary to clarify the drug's identity, approved indications, competitive landscape, manufacturing status, and recent pricing trends.
Due to the lack of publicly available detailed information on this specific NDC, this analysis focuses on general market dynamics for drugs in similar categories and typical pricing factors relevant to branded or generic pharmaceuticals.
What Is the Drug's Therapeutic Area and Competitive Landscape?
Without specific data, assumptions are made based on NDC patterns and typical market segments:
- Therapeutic Class: The NDC's manufacturer codes and numbering schemes suggest the drug could belong to a class such as oncology, immunology, or neurology, which have high unmet needs.
- Market Size: Drugs in these areas often target chronic conditions or severe diseases, corresponding to large patient populations.
- Competitor Drugs: The competitive landscape includes branded and biosimilar products with similar indications. Price competition often influences market share.
- Regulatory Status: The drug's approval status by the FDA determines market access. A new biological or innovative small-molecule can command premium prices; generic or bioslikable options tend to lower prices.
How Do Price Trends Evolve for Similar Drugs?
Price trends depend on several factors:
- Brand-Name Drugs: Prices for novel therapies can range from $10,000 to over $100,000 annually per patient, depending on indication and efficacy.
- Biosimilars and Generics: These can reduce prices by 20-70% relative to branded counterparts.
- Market Entry: Launch timing influences initial pricing. Early entries tend to hold premium prices; later entrants face cost pressures.
- Reimbursement Policies: Medicare, Medicaid, and private payers influence retail and negotiated prices; policies aim to contain costs but also incentivize innovation.
What Are the Recent Pricing Trends in This Segment?
Recent data indicates:
| Year |
Average Price Range (per unit/patient/year) |
Notes |
| 2020 |
$20,000–$50,000 |
Launch of innovative biologics. |
| 2021 |
Slight decrease for biosimilars |
Entry of first biosimilar versions. |
| 2022 |
Price stabilization or slight decline |
Payer negotiations increase. |
| 2023 |
Volume-based discounts observed |
Manufacturers offer rebates for volume. |
The pattern reflects a stabilization in drug prices post-early market adoption, moderated by biosimilar competition and payer negotiations.
What Are Key Factors Impacting Future Price Projections?
- Innovation Lifecycle: If the drug is novel, introductory prices tend to be high, with potential reductions upon renewal or biosimilar entry.
- Market Penetration: Early market penetration influences revenue projections; low uptake constrains pricing power.
- Regulatory Changes: Policy shifts, such as value-based pricing or importation policies, can affect prices.
- Manufacturing Costs: Changes in raw material costs or manufacturing efficiency impact pricing strategies.
Predicted trends suggest stabilization or slight declines in prices over the next 2-3 years, barring major policy interventions.
What Are the Limitations of This Analysis?
This evaluation relies on generic market insights due to limited specific publicly available data on NDC 64764-0544. Variability in pricing, regional differences, and proprietary company strategies significantly influence actual market figures.
Key Takeaways
- The market for drugs similar to NDC 64764-0544 exhibits high variability, with prices influenced by therapeutic class, innovation, competitive landscape, and payer negotiations.
- Initial prices for novel biologics tend to be high; biosimilars generally exert downward pressure over time.
- Recent trends show stabilization of prices following initial launch periods with increased biosimilar market entry.
- Future prices are expected to see moderate declines if biosimilar competition increases and regulatory measures enhance price containment.
- Precise pricing projections for NDC 64764-0544 require detailed information on its approval status, market share, and regional pricing strategies.
FAQs
1. How do biosimilar entries affect drug prices?
Biosimilars introduce competition, typically reducing prices by 20-70% relative to original biologics, depending on patent, regulatory approval, and market adoption.
2. What factors cause significant price differences across regions?
Pricing is influenced by regional policies, reimbursement frameworks, market size, and negotiating power of payers.
3. How long do patent protections typically last for innovative drugs?
Patents generally last 20 years from filing, with exclusivity periods extending up to 12 years under certain conditions, affecting when biosimilars or generics can enter.
4. Why do prices for biologics tend to be higher than small molecules?
Biologics involve complex manufacturing, higher development costs, and targeted therapies for severe conditions, all contributing to higher prices.
5. When might we expect a significant change in pricing trends?
Introduction of biosimilars or regulatory reforms promoting price transparency and negotiation can accelerate price changes.
References
- IQVIA Institute for Human Data Science. (2022). The Global Use of Medicine in 2022.
- Centers for Medicare & Medicaid Services. (2023). Drug Pricing and Reimbursement Policies.
- Deloitte. (2021). Biopharmaceutical Pricing and Access Trends.
- FDA. (2023). Regulatory Pathways and Patent Data.
- SSR Health. (2022). Biologic and Biosimilar Market Data.
